As DnaJB1 positively regulates the epidermal growth factor receptors (EGFR) signaling, knockdown of DnaJB1 promotes the sensitivity of tumor cells to anti-cancer effects of the EGFR inhibitor gefitinib in human lung epithelial adenocarcinoma cells [31]. This evidence concerns the gene DNAJB1 and cancer.